Low-dose Combination of Three Antihypertensive Drugs
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT02710552
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT02710552
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT02710552. Randomized; single masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2019-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Low-dose Combination of Three Antihypertensive Drugs
- Acronym
- 3D
- Condition
- Arterial Hypertension
- Intervention (Drug)
- Tripliam (perindopril, indapamide, amlodipine)
- Intervention (Drug)
- Reaptan (perindopril, amlodipine)
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct02710552- Content hash
66385b77f66c3480338d8cee8098381c170b210802cb76f4b795bb89b189b3d7